FindTrial
Sign In

Comparing Inj Vitamin D versus Inj Acyclovir to find which drug is better to treat warts which do not resolve with other treatment options.

Evaluation of efficacy of intralesional Inj. Vitamin D versus intralesional Inj. Acyclovir in the treatment of recalcitrant cutaneous warts: A randomised clinical trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077629
Enrollment
40
Registered
2024-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Inj Vitamin D: Inj Vitamin D3 (0.2mL, 15mg/dl) injected into the base of the warts after injecting with lidocaine (0.2mL, 15mg/dl) Control Intervention1: Inj Acyclovir: Intralesional

Sponsors

Ashrita Krishna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 or more recalcitrant warts (defined here as warts persistent for a period of more than 6 months, resistant to at least 2 conventional treatment modalities) Extragenital warts. Patients willing to give informed written consent for the study.

Exclusion criteria

Exclusion criteria: Mucosal warts, Pregnancy, lactation, Immunosuppression

Design outcomes

Primary

MeasureTime frame
Achieving Visual analogue score 4Timepoint: week 8—

Secondary

MeasureTime frame
Visual analogue score 4Timepoint: week 2,4,6—

Countries

India

Contacts

Public ContactAshrita Krishna

Hassan Institute Of Medical Sciences

drsureshhsn@gmail.com9632221374

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026